Retrospective study for optimal regimen of neoadjuvant chemotherapy for advanced epithelial ovarian cancers.
Not Applicable
- Conditions
- Advanced epithelial ovarian, fallopian tube, and peritoneal cancers.
- Registration Number
- JPRN-UMIN000039539
- Lead Sponsor
- Sankai Gynecology Study Group (SGSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 497
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with sarcomatous components (including carcinosarcoma). 2) Patients with borderline malignancy. 3) Patient who underwent primary debulking surgery for epithelial ovarian cancer without NAC.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival
- Secondary Outcome Measures
Name Time Method